Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Sysmex Corporation
  6. Summary
    6869   JP3351100007

SYSMEX CORPORATION

(6869)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Japan Exchange
10/18/2021 10/19/2021 10/20/2021 10/21/2021 10/22/2021 Date
13865 14005 14030 13990 13995 Last
328100 303500 328400 289800 299000 Volume
-1.94% +1.01% +0.18% -0.29% +0.04% Change
Estimated financial data (e)
Sales 2022 350 B 3 085 M 3 085 M
Net income 2022 43 367 M 382 M 382 M
Net cash position 2022 65 799 M 580 M 580 M
P/E ratio 2022 67,5x
Yield 2022 0,54%
Sales 2023 384 B 3 382 M 3 382 M
Net income 2023 50 820 M 448 M 448 M
Net cash position 2023 86 268 M 760 M 760 M
P/E ratio 2023 57,6x
Yield 2023 0,59%
Capitalization 2 925 B 25 726 M 25 773 M
EV / Sales 2022 8,17x
EV / Sales 2023 7,40x
Nbr of Employees 8 445
Free-Float 73,0%
More Financials
Company
Sysmex Corp is a Japan-based company principally engaged in the health care business. The Company conducts product development, manufacturing, sales, and service in domestic markets, and some products are developed, manufactured, and sold by subsidiaries. Overseas, the Company conducts the manufacturing and sales of products in the Americas, EMEA, China, and Asia Pacific through other companies. Along with its... 
More about the company
Ratings of Sysmex Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about SYSMEX CORPORATION
10/04SYSMEX : Launches Caresphere™ XQC, an External Quality Assessment App- Enhancing the..
PU
10/01SYSMEX : Starts Implementing Job-Based HR Management System for All Employees (PDF:..
PU
09/29SYSMEX CORPORATION : Ex-dividend day for interim dividend
FA
09/21SYSMEX : Notice Concerning Absorption-Type Merger (Simplified/Short-Form Merger) of Wholly..
PU
09/03SYSMEX : Approval of "Genetic Diagnosis and Counseling for Inherited Retinal Dystrophy" Us..
PU
08/25SYSMEX : Information about Judgment of the Litigation against Sysmex Corporation and its S..
PU
08/06SYSMEX : Summary of Consolidated Financial Results for the First Three Months of the Fisca..
PU
07/26SYSMEX : Corporate Governance Report
PU
07/01QIAGEN N : Allies with Sysmex for Development, Commercialization of Cancer Companion Diagn..
MT
07/01QIAGEN Forms Strategic Alliance with Sysmex Corporation for Global Cancer Companion Dia..
CI
06/08Th2 Chemokine TARC Kit 'HISCL TARC Assay Kit' is Approved for an Additional Indication ..
AQ
06/02Sysmex America Adds FDA-Cleared XN-10 Blood Bank Mode to Hematology Solutions Portfolio
CI
06/02Japan shares rally as reopening hopes boosts travel, real estate firms
RE
06/01Japan shares rally as reopening hopes boosts travel, real estate firms
RE
05/19ThinkCyte, Inc. announced that it has received ¥2.85 billion in funding from Sysmex Cor..
CI
More news
News in other languages on SYSMEX CORPORATION
07/01Qiagen und Sysmex wollen Begleitdiagnostika für Krebserkrankungen anbieten
01/25BOURSE ZURICH : les indices en montagnes russes pour la 1ère séance de la semaine
01/25DPA-AFX-ÜBERBLICK : UNTERNEHMEN vom 25.01.2021 - 15.15 Uhr
01/25BOURSE ZURICH : gains renforcés, le SMI sous les 11'000 points
01/25ROCHE : résultats d'essais prometteurs pour un traitement en ophtalmologie
More news
Chart SYSMEX CORPORATION
Duration : Period :
Sysmex Corporation Technical Analysis Chart | 6869 | JP3351100007 | MarketScreener
Technical analysis trends SYSMEX CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 14
Last Close Price 13 995,00 JPY
Average target price 14 215,38 JPY
Spread / Average Target 1,57%
EPS Revisions
Managers and Directors
Hisashi Ietsugu Chairman, Chief Executive Officer & President
Yukio Nakajima CFO, Director & Senior Managing Executive Officer
Kaoru Asano Director, CTO & COO-LS Business Unit
Yasuhiro Takachi Manager-Informatics
Tomoo Aramaki GM-Corporate Administration & Manager-Accounting
Sector and Competitors
1st jan.Capi. (M$)
SYSMEX CORPORATION12.86%25 710
ABBOTT LABORATORIES14.21%221 691
MEDTRONIC PLC3.85%163 718
BECTON, DICKINSON AND COMPANY-1.50%70 784
HOYA CORPORATION21.65%55 133
DEXCOM, INC.53.24%54 963